← Open Payments lookup

MICHAEL SCHULTZ: Open Payments

NPI 1396727533 · NEW HAVEN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,000 in 95 payments from 15 companies in 2025. Trend: 2023 $1,033 · 2024 $1,864 · 2025 $2,000

Food & beverage: $1,980Education: $20
CompanyPaymentsAmount
ABBVIE INC.35$681
Janssen Biotech, Inc.11$221
Takeda Pharmaceuticals U.S.A., Inc.8$220
Ardelyx, Inc.9$181
Phathom Pharmaceuticals, Inc.5$116
PFIZER INC.6$110
Madrigal Pharmaceuticals3$98
Gilead Sciences, Inc.5$92
Regeneron Healthcare Solutions, Inc.3$84
VIVUS LLC3$64

Products named: RINVOQ, TREMFYA, ENTYVIO, IBSRELA, LINZESS, VOQUEZNA, SKYRIZI, REZDIFFRA.

Industry payments across CT — which companies pay providers there.